Cargando…

Editorial: Antimycobacterial drug discovery: molecular therapeutics and target identification, Volume II

Detalles Bibliográficos
Autores principales:	Gunosewoyo, Hendra, Kruger, Gert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367545/ https://www.ncbi.nlm.nih.gov/pubmed/37497109 http://dx.doi.org/10.3389/fphar.2023.1202287

Ejemplares similares

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
por: Gunosewoyo, Hendra, et al.
Publicado: (2022)

Editorial: Drug-ability strategies for potential antimycobacterial candidate: opportunities and challenges
por: Swain, Shasank Sekhar, et al.
Publicado: (2023)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Editorial: Molecular mechanisms and new therapeutic targets in epithelial to mesenchymal transition (EMT) and fibrosis, volume II
por: Battistelli, Cecilia, et al.
Publicado: (2022)

Editorial: Therapeutic and Diagnosis Target Discovery Based on Metabolomics
por: Liu, Linsheng
Publicado: (2022)

Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets
por: Alsayed, Shahinda S. R., et al.
Publicado: (2023)

Editorial: Platelets in Disease: From Biomarkers Discovery to Therapeutic Targets
por: Zhao, Fan, et al.
Publicado: (2022)

Editorial: Novel therapeutic approaches for the treatment of ocular disease, Volume II
por: Thermos, Kyriaki, et al.
Publicado: (2022)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: Therapeutic Index for Nutraceuticals in Inflammation-Related Diseases: Efficacy, Bioavailability, Metabolism and Interactions With Drugs, Volume II
por: Peluso, Ilaria, et al.
Publicado: (2022)

Editorial: New Paradigms in Neuroscience and Related Targets for Drug Discovery
por: Salomone, Salvatore
Publicado: (2020)

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
por: Zhang, Rui, et al.
Publicado: (2020)

Editorial: Purinergic pharmacology, Volume II
por: Ciruela, Francisco, et al.
Publicado: (2023)

Editorial: Eicosanoids in cancer, Volume II
por: Patrignani, Paola, et al.
Publicado: (2023)

Editorial: Chemoinformatics Approaches to Structure- and Ligand-Based Drug Design, Volume II
por: Ferreira, Leonardo L. G., et al.
Publicado: (2022)

Editorial: Pharmacokinetic evaluation and modeling of clinically significant drug metabolites, Volume II
por: Mikov, Momir, et al.
Publicado: (2023)

Editorial: Natural products as drivers in drug development for neurodegenerative disorders, volume II
por: Silva, Joana, et al.
Publicado: (2023)

Editorial: Vascular smooth muscle cell fate and vascular remodeling: Mechanisms, therapeutic targets, and drugs, volume I
por: Wang, Qilong, et al.
Publicado: (2022)

Editorial: Natural products as an emerging therapeutic alternative for the treatment of anxiety and depression, Volume II
por: Khan, Ajmal, et al.
Publicado: (2022)

Editorial: New insights into renal fibrosis and therapeutic effects of natural products volume II
por: Chen, Dan-Qian, et al.
Publicado: (2022)

Editorial: Therapeutic drug monitoring (TDM): a useful tool for pediatric pharmacology applied to routine clinical practice, Volume II
por: Simeoli, Raffaele
Publicado: (2023)

Editorial: Targeted cancer therapies, from small molecules to antibodies, volume II
por: Su, Chao-Yue, et al.
Publicado: (2023)

Antimycobacterial drug discovery using Mycobacteria-infected amoebae identifies anti-infectives and new molecular targets
por: Trofimov, Valentin, et al.
Publicado: (2018)

Editorial: Developing Medicines (Drugs) derived from the Asteraceae—an opportunity in ethnopharmacology, Volume II
por: da Silva, Luis Cláudio Nascimento, et al.
Publicado: (2023)

Editorial: Targeted drug discovery in ectopic calcification: mechanism, prospect, and clinical application
por: Xu, Kang, et al.
Publicado: (2023)

Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
por: Rudrapal, Mithun, et al.
Publicado: (2022)

Editorial: Medicinal Cannabis: evolution of therapeutic use, future approaches and other implications, volume II
por: Baratta, Francesca, et al.
Publicado: (2023)

Editorial: Pharmaceutical Innovation After World War II: From Rational Drug Discovery to Biopharmaceuticals
por: Zarros, Apostolos, et al.
Publicado: (2019)

Editorial: Computational drug discovery for targeting of protein-protein interfaces—Volume II
por: Morra, Giulia, et al.
Publicado: (2023)

Editorial: Novel therapeutic approaches to target drug resistant tumors
por: Riganti, Chiara, et al.
Publicado: (2023)

Editorial: Venoms, animal and microbial toxins, volume II
por: Cao, Zhijian, et al.
Publicado: (2022)

Editorial: Current Aspects in Chemopreventive Strategies, Volume II
por: Tuli, Hardeep Singh, et al.
Publicado: (2022)

Editorial: Autophagy in inflammation related diseases, volume II
por: Shao, Bo-Zong, et al.
Publicado: (2023)

Editorial: Antimalarial chemotherapy in the XXIst century, volume II
por: Gomes, Paula, et al.
Publicado: (2023)

Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2023)

Specific gene module pair-based target identification and drug discovery
por: Li, Peng, et al.
Publicado: (2023)

Targeting Energy Metabolism in Mycobacterium tuberculosis, a New Paradigm in Antimycobacterial Drug Discovery
por: Bald, Dirk, et al.
Publicado: (2017)

Editorial: Insights in Experimental Pharmacology and Drug Discovery: 2021
por: Trostchansky, Andres, et al.
Publicado: (2022)

Editorial: Women in experimental pharmacology and drug discovery: 2021
por: Rižner, Tea Lanišnik, et al.
Publicado: (2022)

Editorial: Insights in experimental pharmacology and drug discovery: 2022
por: Latini, Alexandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7dotuudjjkrnplm9u98di5dgsj